Organon Historical Income Statement

OGN Stock  USD 15.36  0.30  1.92%   
Historical analysis of Organon income statement accounts such as Total Revenue of 6.3 B can show how well Organon Co performed in making a profits. Evaluating Organon income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Organon's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Organon latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Organon is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

About Organon Income Statement Analysis

Organon Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Organon shareholders. The income statement also shows Organon investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Organon Income Statement Chart

At this time, Organon's Net Income is very stable compared to the past year. As of the 4th of December 2024, Depreciation And Amortization is likely to grow to about 372.1 M, while Tax Provision is likely to drop about 90.2 M.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Organon generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Organon Co minus its cost of goods sold. It is profit before Organon operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Organon's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Organon current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
At this time, Organon's Net Income is very stable compared to the past year. As of the 4th of December 2024, Depreciation And Amortization is likely to grow to about 372.1 M, while Tax Provision is likely to drop about 90.2 M.
 2021 2022 2023 2024 (projected)
Interest Expense258M422M527M553.4M
Tax Provision178M205M95M90.3M

Organon income statement Correlations

-0.760.930.960.920.70.760.920.760.190.980.530.910.920.57-0.360.860.490.920.860.67-0.780.52
-0.76-0.59-0.84-0.9-0.89-0.9-0.73-0.97-0.68-0.85-0.3-0.66-0.69-0.930.79-0.880.08-0.67-0.97-0.660.95-0.78
0.93-0.590.910.780.470.550.950.57-0.040.870.60.950.970.35-0.070.750.740.950.740.63-0.620.42
0.96-0.840.910.950.780.830.970.830.350.950.60.950.940.67-0.470.950.450.950.940.69-0.880.54
0.92-0.90.780.950.910.940.850.940.540.940.590.850.810.83-0.650.970.20.860.940.75-0.920.6
0.7-0.890.470.780.910.990.620.960.830.750.490.610.540.94-0.90.91-0.160.620.860.57-0.930.5
0.76-0.90.550.830.940.990.680.960.770.80.510.680.610.92-0.860.94-0.080.690.90.61-0.940.51
0.92-0.730.950.970.850.620.680.690.170.890.560.960.990.5-0.290.860.620.970.870.6-0.780.45
0.76-0.970.570.830.940.960.960.690.750.840.420.670.640.97-0.830.92-0.110.680.940.71-0.950.72
0.19-0.68-0.040.350.540.830.770.170.750.280.280.170.080.87-0.950.61-0.580.170.570.29-0.70.34
0.98-0.850.870.950.940.750.80.890.840.280.420.880.880.68-0.460.880.350.880.910.75-0.820.67
0.53-0.30.60.60.590.490.510.560.420.280.420.660.550.33-0.170.620.450.660.420.41-0.45-0.04
0.91-0.660.950.950.850.610.680.960.670.170.880.660.950.49-0.250.870.641.00.820.71-0.710.41
0.92-0.690.970.940.810.540.610.990.640.080.880.550.950.45-0.190.810.660.950.830.63-0.730.5
0.57-0.930.350.670.830.940.920.50.970.870.680.330.490.45-0.920.83-0.340.490.850.64-0.890.7
-0.360.79-0.07-0.47-0.65-0.9-0.86-0.29-0.83-0.95-0.46-0.17-0.25-0.19-0.92-0.690.54-0.26-0.68-0.350.79-0.45
0.86-0.880.750.950.970.910.940.860.920.610.880.620.870.810.83-0.690.210.880.950.72-0.930.53
0.490.080.740.450.2-0.16-0.080.62-0.11-0.580.350.450.640.66-0.340.540.210.630.160.15-0.02-0.16
0.92-0.670.950.950.860.620.690.970.680.170.880.661.00.950.49-0.260.880.630.830.71-0.710.41
0.86-0.970.740.940.940.860.90.870.940.570.910.420.820.830.85-0.680.950.160.830.68-0.950.69
0.67-0.660.630.690.750.570.610.60.710.290.750.410.710.630.64-0.350.720.150.710.68-0.560.76
-0.780.95-0.62-0.88-0.92-0.93-0.94-0.78-0.95-0.7-0.82-0.45-0.71-0.73-0.890.79-0.93-0.02-0.71-0.95-0.56-0.61
0.52-0.780.420.540.60.50.510.450.720.340.67-0.040.410.50.7-0.450.53-0.160.410.690.76-0.61
Click cells to compare fundamentals

Organon Account Relationship Matchups

Organon income statement Accounts

201920202021202220232024 (projected)
Tax Provision337M520M178M205M95M90.3M
Selling General Administrative1.2B1.5B1.4B1.4B1.7B1.3B
Total Revenue7.8B8.1B6.3B6.2B6.3B6.3B
Gross Profit5.5B4.7B3.9B3.9B3.7B3.7B
Operating Income3.8B2.8B1.6B1.5B1.3B1.9B
Ebit3.8B2.8B1.6B1.5B1.2B2.0B
Cost Of Revenue2.3B3.3B2.4B2.3B2.5B2.5B
Income Before Tax3.7B2.7B1.5B1.1B673M639.4M
Net Income Applicable To Common Shares3.2B2.2B1.4B917M825.3M1.5B
Net Income3.2B2.2B1.4B917M1.0B1.4B
Income Tax Expense390M520M178M205M(350M)(332.5M)
Depreciation And Amortization333M142M195M212M236M372.1M
Other Operating Expenses3.9B5.3B4.5B4.5B4.9B4.0B
Net Income From Continuing Ops3.2B2.2B1.4B917M585M555.8M
Research Development220M304M443M471M528M427.4M
Ebitda4.2B3.0B1.8B1.7B1.4B2.2B
Total Operating Expenses1.7B2.0B2.1B2.2B2.4B2.3B
Reconciled Depreciation354M157M195M212M228M375.9M
Total Other Income Expense Net(151M)(95M)(386M)(583M)(656M)(623.2M)

Pair Trading with Organon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.

Moving together with Organon Stock

  0.7VRAX Virax Biolabs GroupPairCorr

Moving against Organon Stock

  0.9VRNA Verona Pharma PLCPairCorr
  0.89ETON Eton Pharmaceuticals Potential GrowthPairCorr
  0.82EWTX Edgewise TherapeuticsPairCorr
  0.73ELDN Eledon PharmaceuticalsPairCorr
  0.53DSGN Design TherapeuticsPairCorr
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.081
Dividend Share
1.12
Earnings Share
5.05
Revenue Per Share
24.984
Quarterly Revenue Growth
0.041
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.